A Member of the Roche Group
Poseida Therapeutics, Inc., a Member of the Roche Group, is dedicated to advancing innovative therapies in the field of biotechnology. Located in San Diego, California, Poseida Therapeutics, Inc. is committed to developing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure.
Poseida Therapeutics, Inc.’s approach is based on its proprietary genetic editing platforms, including its non-viral DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing. The primary address of Poseida Therapeutics, Inc. is 9390 Towne Centre Dr, 200, San Diego, California 92121, US. This strategic location enables Poseida to foster innovation and collaboration within the vibrant San Diego biotechnology community.
Poseida Therapeutics, Inc. is focused on making a significant impact on healthcare through groundbreaking research and development. We invite the manager of Poseida Therapeutics, Inc. to create a customized and exclusive company showcase and product listing on our platform, further enhancing their visibility and commercial development.
Compare Poseida Therapeutics, Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
Poseida Therapeutics, Inc...Main Company |
MaxCyte, Inc.View Profile |
Morgan Prestwich - L...View Profile |
Advanced Therapies,...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1999 | 2010 | 2004 |
|
Company Size
|
— | 51-200 | 11-50 | 501-1,000 |
|
City
|
San Diego, California | Rockville, Maryland | Reigate, Surrey | Philadelphia, Pennsylvania |
|
Country
|
United States | United States | United Kingdom | United States |
|
Skills & Keywords
Comparing with main company
|
25 Total Skills
Biotechnology
Cell Therapy
Gene Editing
Immunotherapy
Genetic Medicines
Regenerative Medicine
Oncology
T-cells
Transposon
piggyBac®
Non-viral
Genome Engineering
Cytotoxic T Lymphocytes
CAR-T cells
Cas-CLOVER™
Prostate Cancer
Gene Therapy
Allogeneic
Immunology
Immuno-oncology
Adoptive Cell Therapy
Multiple Myeloma
Poseida
piggyBac® DNA Modification System
TAL-CLOVER™
|
15 Total
15 Unique
Unique Skills:
Bispecifics
Cancer
Cancer Research
CARMA
Cell Engineering
Electroporation
+9
|
51 Total
51 Unique
Unique Skills:
Biotech
Biotech Recruitment
Biotechnology Recruitment
Boards
Business Development
C-Level
+45
|
28 Total
28 Unique
Unique Skills:
AAV
Adventitious Agent Testing
Analytical Development
Antibody Drug Conjugate
Autologous
Biologics
+22
|
Other organizations in the same industry
This company is also known as